Search

Showing "11154" results for ""

Black Americans respond less well to interferon treatment for HCV

New viral load test could be used wherever a car can go, says developer

New technique enables diagnosis of HIV within a week of infection, measures viral load to 2 copies

Over a quarter of HIV-positive children on treatment have lipodystrophy in European study

Harmless virus slows HIV progression by stimulating chemokine release

Evaluation of a new TB test highlights ongoing dilemmas of TB/HIV management

Risk of severe liver toxicities if nevirapine used in HAART in pregnant women with CD4 above 250

Zimbabwe begins manufacture of ARVs

World Bank gives $60 million for HIV treatment in Burkina Faso, Mozambique, Ghana

Cote D’Ivoire, Gabon, announce major reductions in HIV drug prices for citizens

Uganda begins free antiretroviral programme

Infection with drug-resistant HIV has little effect on CD4 cell counts in the absence of therapy

Once-daily treatment not a golden bullet for improved adherence, multiple factors important

Vietnam chosen as Asian recipient of PEPFAR treatment funds

HIV-positive teenage girls have higher risk of future cervical cancer

EuroSIDA: patients with higher baseline CD4 have higher risk of immunologic failure on HAART

Treatment failure due to drug resistance not a major cause of death

Detectable CMV predicts new AIDS events and deaths even with HAART

Receive the latest HIV research and conference news

Showing "11154" results for ""

Black Americans respond less well to interferon treatment for HCV

New viral load test could be used wherever a car can go, says developer

New technique enables diagnosis of HIV within a week of infection, measures viral load to 2 copies

Over a quarter of HIV-positive children on treatment have lipodystrophy in European study

Harmless virus slows HIV progression by stimulating chemokine release

Evaluation of a new TB test highlights ongoing dilemmas of TB/HIV management

Risk of severe liver toxicities if nevirapine used in HAART in pregnant women with CD4 above 250

Zimbabwe begins manufacture of ARVs

World Bank gives $60 million for HIV treatment in Burkina Faso, Mozambique, Ghana

Cote D’Ivoire, Gabon, announce major reductions in HIV drug prices for citizens

Uganda begins free antiretroviral programme

Infection with drug-resistant HIV has little effect on CD4 cell counts in the absence of therapy

Once-daily treatment not a golden bullet for improved adherence, multiple factors important

Vietnam chosen as Asian recipient of PEPFAR treatment funds

HIV-positive teenage girls have higher risk of future cervical cancer

EuroSIDA: patients with higher baseline CD4 have higher risk of immunologic failure on HAART

Treatment failure due to drug resistance not a major cause of death

Detectable CMV predicts new AIDS events and deaths even with HAART

Receive the latest HIV research and conference news